News

TAE Life Sciences Celebrates Collaboration Milestones and Unveils Alphabeam for in-hospital BNCT at ASTRO 2023 Annual Meeting

SAN DIEGO and IRVINE, Calif., Sept. 28, 2023 /PRNewswire/ — TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, is thrilled to announce it is bringing BNCT to this […]

News

Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem’s Phexxi Patents Expire

— Padagis Determined They Will Not Challenge the Phexxi Patents — — Evofem Has Phexxi Patent Protection Through 2033 — SAN DIEGO, Sept. 27, 2023 /PRNewswire/ — Evofem Biosciences, Inc., (OTCQB: EVFM) today announced that […]

News

Ionis enters agreement with Roche for two novel RNA-targeted programs for Alzheimer’s disease and Huntington’s disease

Roche gains exclusive worldwide rights to develop, manufacture and commercialize the investigational medicines discovered by Ionis Ionis to receive a $60 million upfront payment CARLSBAD, Calif., Sept. 27, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: […]

News

THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS

Innovative Multimillion-Dollar Grant Was Created in 2022 to Drive Biopharma Industry to Speed Development of Pancreatic Cancer Therapies BOSTON, SAN DIEGO, and CALGARY, AB, Sept. 26, 2023 /PRNewswire/ — In an effort to continue accelerating […]

News

Kintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual Meeting

SAN DIEGO, Sept. 25, 2023 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor therapies, today announced the presentation of compelling patient […]

No Picture
News

Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company

SAN DIEGO, Sept. 22, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento” or “Company”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced the […]

No Picture
News

Monoceros Biosystems and SeekIn Join Forces to Pave the Way for Cutting-Edge AI-Powered Cancer Diagnostics

SAN DIEGO, Sept. 21, 2023 /PRNewswire/ — Monoceros Biosystems, a prominent bioinformatics service provider in the United States, is thrilled to announce a strategic partnership with SeekIn, a leading liquid biopsy testing provider in China, […]

No Picture
News

HILLHURST BIOPHARMACEUTICALS RECEIVES $3 MILLION IN NIH SBIR FUNDING FOR PHASE 2A CLINICAL STUDY IN SICKLE CELL DISEASE

SAN DIEGO, Sept. 20, 2023 /PRNewswire/ — Hillhurst Biopharmaceuticals, Inc. (“Hillhurst”), a clinical-stage biopharmaceutical company focused on developing liquid drug products containing therapeutic gases, today announced the award of an approximately $3 million Phase 2b […]

No Picture
News

Regulus Therapeutics Announces Positive Topline Data from the First Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Statistically significant increase in urinary polycystin 1(PC1) after treatment with RGLS8429 Urinary polycystin exhibits anticipated pharmacokinetics/pharmacodynamics (PK/PD) correlation in patients with ADPKD Company to hold conference call at 8:30 a.m. EDT today SAN DIEGO, Sept. […]

News

Inhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United States and Canada

SAN DIEGO, Sept. 19, 2023 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, announced today that Chiesi Farmaceutici S.p.A (“Chiesi”) declined to […]

News

CureScience™ Institute Fall-Spring Scholars Bioinformatics and Machine Learning Program

SAN DIEGO, Sept. 19, 2023 /PRNewswire/ — CureScience™ Institute, a San Diego, California based non-profit 501(c)(3) dedicated to accelerating cures based on a combination of diagnostic, immunological, and regenerative approaches, proudly announce that Professor Igor […]

News

Fresh Start Surgical Gifts Presents the 2023 Annual Oktoberfest Butterfly Gala: A Night of Hope and Transformation

SAN DIEGO, Sept. 18, 2023 /PRNewswire/ — National nonprofit, Fresh Start Surgical Gifts is excited to announce its highly anticipated 2023 Annual Oktoberfest Butterfly Gala, a celebration that promises an unforgettable evening of transforming lives, […]

News

Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update

SAN DIEGO, Sept. 18, 2023 /PRNewswire/ — Kintara Therapeutics, Inc. (NASDAQ: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its […]

News

Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board

SAN DIEGO, Sept. 14, 2023 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today announced that Professor Shun Lu, an internationally renowned oncologist […]

News

Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Application for INGREZZA® (valbenazine) Oral Granules Sprinkle Formulation

Prescription Drug User Fee Act (PDUFA) Target Action Date Set for April 30, 2024 SAN DIEGO, Sept. 14, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration (FDA) […]